The Academy of Medical Sciences has elected University of Birmingham Professor Arri Coomarasamy as one of 50 of the UK's leading figures within biomedical and health sciences to their esteemed Fellowship.
Research led by the University of Birmingham suggests that giving progesterone to pregnant women with early pregnancy bleeding and a history of miscarriage could increase their chances of having a baby.
Four researchers from the College of Medical and Dental Sciences have received funding from the Academy of Medical Sciences, Marie Skłodowska-Curie Actions and Cancer Research UK to further their scientific endeavours.
Treating women with thyroid antibodies but a normal thyroid function with a medicine called Levothyroxine does not make them more likely to deliver a live baby, new research led by the University of Birmingham suggests.
Research led by the University of Birmingham has found that increased levels of hormones including testosterone could cause a brain condition that can lead to blindness in women.
New international guidelines on how to provide treatment for women having miscarriage surgery are needed after a large-scale international trial led by the University of Birmingham.
Research carried out in collaboration with the University of Birmingham has found that genetic testing improves the diagnoses of abnormalities in developing babies that are picked up during ultrasound scans.
The aim of this Cochrane Review was to find out which drug is most effective in preventing excessive blood loss at childbirth and has the least side effects. The authors collected and analysed all the relevant studies to answer this question.
A leading expert in fetal medicine at the University of Birmingham has warned that there is 'little room for complacency' over a fall in twin stillbirth rates as the reason for this phenomenon are complex.
Professor Davide Calebiro, Professor of Molecular Endocrinology and Wellcome Senior Research Fellow, Institute of Metabolism and Systems Research, gave an outstanding inaugural lecture on hormone receptors at the Leonard Deacon Lecture Theatre, University of Birmingham, this month.